MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

We Did The Math IWO Can Go To $163
Tuesday, April 12, 7:49 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

How The Parts Add Up: THRK Headed For $171
Friday, May 13, 7:38 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Predict 41% Upside For IBB
Thursday, June 16, 8:25 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Anticipate UBIO Will Reach $32
Monday, July 18, 8:03 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Notable Tuesday Option Activity: CALD, CSTE, RIGL
Tuesday, August 2, 3:30 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

  More articles:  1 2 3 4 5 6 next »

Rigel Pharmaceuticals Inc Becomes Oversold (RIGL)

By Market News Video Staff, Friday, May 3, 4:24 PM ET
Play Video: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Rigel Pharmaceuticals Inc (NASDAQ:RIGL) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $4.65 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 64.8. A bullish investor could look at RIGL's 28.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of RIGL shares:

Rigel Pharmaceuticals Inc 1 Year Performance Chart

Looking at the chart above, RIGL's low point in its 52 week range is $4.41 per share, with $11.44 as the 52 week high point that compares with a last trade of $4.65. Find out what 9 other oversold stocks you need to know about


Special Offer: Manage the risks of the markets better with a free 30 day trial to the Strategic Risk Management System.


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   Buffett   Know   Looking   Management   Oversold   RIGL   Relative   Special   Start   Strategic   Warren   analysis   below   better   bullish   changing   chart   comparison   entered   entry   falls   fearful   greedy   heavy   into   investor   know   level   look   markets   others   oversold   point   range   raquo   reading   selling   share   shares   sign   stock   technical   territory   that   trading   week   what   when   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

Rigel Pharmaceuticals Inc Becomes Oversold (RIGL) | Market News Video | Copyright © 2008 - 2017, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.